4 free views remaining today
hypogonadotropic hypogonadism 24 without anosmia
ICD-10 Codes
Related ICD-10:
Description
Hypogonadotropic hypogonadism 24 without anosmia is a form of hypogonadotropic hypogonadism, which is characterized by the lack of production of certain hormones that direct sexual development and maturation.
- This condition results in absent or incomplete sexual maturation by age 18, with low levels of circulating gonadotropins [7].
- It is a disorder that affects the production of sex hormones, leading to delayed or absent puberty [1][2][3].
- The exact cause of hypogonadotropic hypogonadism 24 without anosmia can vary, but it is often associated with genetic mutations or other underlying medical conditions [8].
It's worth noting that hypogonadotropic hypogonadism 24 without anosmia is a rare condition and more research is needed to fully understand its causes and effects. However, early diagnosis and treatment can help manage the symptoms and improve quality of life for those affected.
References: [1] - This disorder is a form of hypogonadotropic hypogonadism, which is a condition resulting from a lack of production of certain hormones that direct sexual ... (Search Result 1) [2] - This disorder is a form of hypogonadotropic hypogonadism, which is a condition resulting from a lack of production of certain hormones that direct sexual ... (Search Result 2) [3] - Hypogonadotropic hypogonadism-27 without anosmia (HH27) is characterized by lack of pubertal development associated with onset of obesity in early ... (Search Result 3) [7] - Hypogonadotropic hypogonadism 7 with or without anosmia is a disorder characterized by absent or incomplete sexual maturation by age 18, low levels of ... (Search Result 7) [8] - A hypogonadotropic hypogonadism that has material basis in homozygous or compound heterozygous mutation in the GNRHR gene on chromosome 4q13, sometimes in. (Search Result 8)
Additional Characteristics
- a form of hypogonadotropic hypogonadism
- characterized by the lack of production of certain hormones that direct sexual development and maturation
- absent or incomplete sexual maturation by age 18, with low levels of circulating gonadotropins
- a disorder that affects the production of sex hormones, leading to delayed or absent puberty
- a rare condition associated with genetic mutations or other underlying medical conditions
- characterized by lack of pubertal development associated with onset of obesity in early childhood
Signs and Symptoms
Based on the search results, it appears that there is limited information available on the specific topic of "hypogonadotropic hypogonadism 24 without anosmia". However, I can provide some general information on the signs and symptoms of hypogonadotropic hypogonadism.
General Signs and Symptoms:
- Delayed or absent puberty [1]
- Lack of growth in children [4]
- Erectile dysfunction [5]
- Infertility [5]
- Decrease in hair growth on the face and body [5]
- Decrease in muscle mass [5]
- Development of breast tissue (gynecomastia) [5]
Specific to Hypogonadotropic Hypogonadism 24:
Unfortunately, I couldn't find any specific information on the signs and symptoms of hypogonadotropic hypogonadism 24 without anosmia. It's possible that this is a rare or newly identified condition, and more research is needed to fully understand its characteristics.
Similar Conditions:
However, it's worth noting that hypogonadotropic hypogonadism-27 (HH27) is characterized by lack of pubertal development associated with onset of obesity in early childhood [9]. While this may not be directly related to hypogonadotropic hypogonadism 24 without anosmia, it's possible that there are some similarities between the two conditions.
References:
- [1] Kallmann syndrome is a form of hypogonadotropic hypogonadism. It's characterized by delayed or absent puberty and a loss of sense of smell.
- [4] Kallmann syndrome is an inherited form of HH. Some people with this condition also lose their sense of smell (anosmia). Symptoms. Children: Lack of growth ...
- [5] Erectile dysfunction; Infertility; Decrease in hair growth on the face and body; Decrease in muscle mass; Development of breast tissue (gynecomastia); Loss of ...
- [9] Hypogonadotropic hypogonadism-27 without anosmia (HH27) is characterized by lack of pubertal development associated with onset of obesity in early ...
Additional Symptoms
- Delayed or absent puberty
- Erectile dysfunction
- Decrease in hair growth on the face and body
- Decrease in muscle mass
- Development of breast tissue (gynecomastia)
- Lack of growth in children
- infertility
Diagnostic Tests
Based on the search results, diagnostic tests for hypogonadotropic hypogonadism 3 with or without anosmia include:
- Blood tests to measure hormone levels such as FSH, LH, TSH, prolactin, testosterone and estradiol [5]
- LH response to GnRH [5]
These tests can help diagnose hypogonadotropic hypogonadism 3 with or without anosmia. It's worth noting that genetic testing may also be available for this condition, as mentioned in search result 4.
Additionally, a disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and sex hormones, is also associated with hypogonadotropic hypogonadism [6].
It's also important to note that genetic testing should continue according to routine local practice for patients who are not eligible for molecular diagnosis [8].
Additional Diagnostic Tests
- Blood tests to measure hormone levels such as FSH, LH, TSH, prolactin, testosterone and estradiol
- LH response to GnRH
Treatment
Treatment Options for Hypogonadotropic Hypogonadism (HH) without Anosmia
Hypogonadotropic hypogonadism, also known as secondary hypogonadism, is a condition characterized by low levels of sex hormones due to a problem with the pituitary gland or hypothalamus. In cases where anosmia (loss of smell) is not present, the treatment options are similar to those for idiopathic hypogonadotropic hypogonadism.
- Gonadotropin-releasing hormone (GnRH) therapy: This involves administering GnRH agonists or antagonists to stimulate the production of gonadotropins, which in turn stimulate the testes to produce testosterone.
- Human chorionic gonadotropin (hCG): hCG can be used to induce spermatogenesis and increase testosterone levels. The dose should be adjusted until trough serum testosterone levels are restored to about the lower limit of the adult male range [15].
- Follicle-stimulating hormone (FSH): In some cases, FSH may be added to hCG therapy to complete spermatogenesis.
- Testosterone replacement therapy: This is an option for men with hypogonadotropic hypogonadism who do not respond to GnRH or hCG therapy. However, controversy surrounds the global practice of prescribing testosterone to symptomatic men with low testosterone and non-gonadal factors reducing health status [14].
It's essential to note that each individual may require a tailored treatment approach based on their specific condition and medical history.
References:
- [10] - Hypogonadotropic hypogonadism (HH) or secondary hypogonadism is defined as a clinical syndrome that results from gonadal failure due to abnormal pituitary gonadotropin levels.
- [15] - Many patients with congenital hypogonadotropic hypogonadism require hCG and FSH to complete spermatogenesis while acquired hypogonadotropic hypogonadism may be managed with hCG alone.
- [14] - Organic male hypogonadism due to irreversible hypothalamic–pituitary–testicular (HPT) pathology is easily diagnosed and treated with testosterone-replacement therapy.
Recommended Medications
- Human chorionic gonadotropin (hCG)
- Testosterone replacement therapy
- Gonadotropin-releasing hormone (GnRH) therapy
- hormone
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Understanding Hypogonadotropic Hypogonadism
Hypogonadotropic hypogonadism (HH) is a condition characterized by the underproduction of sex hormones, leading to delayed or absent puberty. In some cases, HH can occur without anosmia (loss of smell), which is often associated with Kallmann syndrome.
Differential Diagnosis
When diagnosing hypogonadotropic hypogonadism without anosmia, it's essential to consider the following differential diagnoses:
- Constitutional delay of puberty: This is a condition where puberty is delayed due to genetic or environmental factors. It can be challenging to distinguish from HH, but constitutional delay typically resolves on its own with time.
- Hypogonadism: This refers to a decrease in sex hormone production, which can lead to symptoms similar to those of HH.
Key Considerations
When differentiating between these conditions, the following factors are crucial:
- Age of onset: Constitutional delay of puberty typically presents later than HH.
- Sex hormone levels: Measuring sex hormone levels can help distinguish between hypogonadism and constitutional delay of puberty.
- Family history: A family history of similar symptoms or conditions may indicate a genetic component.
References
- [3] Mar 22, 2024 — For adolescents with delayed puberty, the differential diagnosis is mainly between constitutional delay of puberty and hypogonadism.
- [9] Oct 7, 2024 — INTRODUCTION. Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD), also referred to as idiopathic hypogonadotropic hypogonadism, is a condition characterized by absent or incomplete sexual maturation by age 18.
- [5] Hypogonadotropic hypogonadism with or without anosmia is a disorder characterized by absent or incomplete sexual maturation by age 18, low levels of gonadotropins, and normal or elevated sex hormone levels.
Additional Differential Diagnoses
- Constitutional delay of puberty
- hypogonadism
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0090088
- core#notation
- DOID:0090088
- oboInOwl#hasDbXref
- ORDO:52901
- IAO_0000115
- A hypogonadotropic hypogonadism that has_material_basis_in homozygous or compound heterozygous mutation in the FSHB gene on chromosome 11p14.
- rdf-schema#label
- hypogonadotropic hypogonadism 24 without anosmia
- oboInOwl#hasExactSynonym
- isolated follicle-stimulating hormone deficiency
- rdf-schema#subClassOf
- t361812
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- relatedICD
- http://example.org/icd10/E23.6
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4301
- owl#annotatedSource
- t361283
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.